Teicoplanin Injectable (IV/IM) Suppliers & Bulk Manufacturers
Available Forms: Injectable (IV/IM)
Available Strengths: 200 mg/100 mL, 400 mg/200 mL, 400 mg/100 mL
Originator reference: Targocid (US & EU) (brand names belong to their owners and are shown only to identify the originator medicine)
Category: Antibiotics
Teicoplanin inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins, causing bacterial lysis. It is effective against gram-positive bacteria, including MRSA. Benefits include long half-life allowing once-daily dosing, rapid bacterial eradication, and safety for severe infections like endocarditis and osteomyelitis, when used properly under supervision.
Manufacture or export Teicoplanin Injectable (IV/IM)? List it or send an offer →
Product Description:
Teicoplanin injectable is approved in the EU and US for severe gram-positive bacterial infections, including MRSA. In the EU, brands like Targocid are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing quality. In the US, approval is limited, with extraregional use mainly in Europe and Asia. Both regions require detailed dossiers, including clinical trial data, manufacturing practices, and pharmacovigilance plans for approval and ongoing safety. We support seamless market access for teicoplanin IV formulations, ensuring adherence to European and US standards for safe, effective antimicrobial therapy.
Teicoplanin Injectable (IV/IM) — third party manufacturing & bulk supply
Teicoplanin Injectable (IV/IM) is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Teicoplanin Injectable (IV/IM) is supplied as Injectable (IV/IM) — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Teicoplanin Injectable (IV/IM) listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Teicoplanin Injectable (IV/IM) →Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.
Frequently Asked Questions
Related Products
Sulfasalazine Tablets/Capsule
Strength:
500 mg, 1000 mg
Form: Tablet/Capsules
Originator reference: Azulfidine(US); Salazopyrin(EU)
View DetailsFosfomycin IV
Strength:
2 g, 4g per vial
Form: Intravenous (IV)
Originator reference: Fomicyt (UK), InfectoFos (DE)
View DetailsSulfamethoxazole / Trimethoprim Suspension
Strength:
80 mg/400 mg per 5 mL, 160 mg/800 mg per 5 mL
Form: Suspension
Originator reference: Bactrim (US)
View DetailsFosfomycin Oral Sachets or Powder for Suspension
Strength:
3g in a sachet
Form: Oral Sachets or Powder for Suspension
Originator reference: -
View DetailsRifaximin
Strength:
100 mg/5 mL, 200 mg, 550 mg
Form: Tablet / Oral Suspension
Originator reference: Xifaxan (USA), Targaxan (EU), Normix (LATAM)
View DetailsIsoniazid + Rifapentine Tablets
Strength:
300 mg/300 mg
Form: Film-coated tablets
Originator reference: -
View DetailsPolymyxin B for Injection
Strength:
500,000 IU (50 mg)
Form: Lyophilised powder vial (IV, IM, intrathecal)
Originator reference:
View DetailsCeftazidime + Avibactam for Injection
Strength:
2 g + 0.5 g
Form: Powder for concentrate vial (IV infusion)
Originator reference: Zavicefta, Avycaz
View DetailsUsually answered within 48 hours | GMP documents shared before you commit